Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Alvespimycin

Alvespimycin (17-DMAG) is a potent inhibitor of Hsp90, binding to Hsp90 with an EC50 of 62 nM.

Product Specifications

CAS Number

467214-20-6

Product Name Alternative

17-DMAG; KOS-1022; NSC 707545

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

HSP

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/alvespimycin.html

Purity

99.52

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C/C1=C\C=C/[C@@H]([C@H](/C(C)=C/[C@@H]([C@H]([C@H](C[C@@H](CC(C(C(NC1=O)=CC2=O)=O)=C2NCCN(C)C)C)OC)O[H])C)OC(N)=O)OC

Molecular Formula

C32H48N4O8

Molecular Weight

616.75

Precautions

H315, H319, H335

References & Citations

[1]Ge J, et al. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90. J Med Chem. 2006 Jul 27;49 (15) :4606-15.|[2]Hertlein E, et al. 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition. Blood. 2010 Jul 8;116 (1) :45-53.|[3]Henke A, et al. Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90. Cancers (Basel) . 2016 Aug 24;8 (9) . pii: E77.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Isoform

HSP90

Citation 01

ACS Biomater Sci Eng. 2021 Nov 8;7 (11) :5154-5164.|Adv Sci (Weinh) . 2025 Jul 29:e01977.|Cell Death Dis. 2022 Jan 21;13 (1) :73.|Exp Ther Med. 2022 Apr;23 (4) :273.|Friedrich-Alexander University Erlangen-Nuremberg. 2016 Sep 14.|NPJ Precis Oncol. 2023 May 18;7 (1) :44.|Pharmacol Res. 2020 Jan;151:104512.|Sci Rep. 2021 May 26;11 (1) :11057.|Theranostics. 2020 Jul 9;10 (18) :8415-8429.|Authorea. April 10, 2021.|Biochim Biophys Acta Mol Cell Res. 2024 Apr;1871 (4) :119703.|bioRxiv. 2021 Jan 27.|Br J Pharmacol. 2021 Nov;178 (22) :4485-4500.|Drug Deliv Transl Res. 2025 Oct 29.|Front Pharmacol. 2022 Jan 14:12:724192.|Nat Commun. 2021 Jul 22;12 (1) :4457.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

GPR148 (NM_207364) Human Over-expression Lysate
LC403985 20 µg

GPR148 (NM_207364) Human Over-expression Lysate

Sign In for Pricing
View Details
1,2-Dibromo-4-(3-bromophenoxy)benzene
TRC-D422895-10MG 10 mg

1,2-Dibromo-4-(3-bromophenoxy)benzene

Sign In for Pricing
View Details
KLF4 (1-170) Mouse Monoclonal Antibody [Clone ID: AT4E6]
AM09057PU-S 50 µL

KLF4 (1-170) Mouse Monoclonal Antibody [Clone ID: AT4E6]

Sign In for Pricing
View Details
CD268 / BAFFR / TNFRSF13C (BAFFR/1557), CF568 conjugate, 0.1mg/mL
BNC681557-100 1x 100 µL

CD268 / BAFFR / TNFRSF13C (BAFFR/1557), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Brilliant Thallium Pioneer - No wash potassium or sodium channel assay kit
11000-2 2 Plates

Brilliant Thallium Pioneer - No wash potassium or sodium channel assay kit

Sign In for Pricing
View Details
CF®647 Free Acid
#92062 1x 1 mg

CF®647 Free Acid

Sign In for Pricing
View Details